Skip to content

Comparing the effectiveness of varmam therapy and exercises in the symptomatic management of patients with shoulder pain

Comparing the effectiveness of varmam therapy and rehabilitation exercises in the symptomatic management of periarthritis shoulder an open randomized, non-inferiority clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105454
Enrollment
90
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Varmam Therapy: 7 varmam points are selected. Each therapy session lasts for 15 minutes. Therapy will be given twice a week for 4 weeks Control Intervention1: Rehabilitation exercises:

Sponsors

Government Siddha Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 2. Unilateral shoulder pain for more than 6 weeks and less than 12 months 3. Significant pain of 50 to 100 mm on a 100 mm pain visual analogue scale during activity 4. Restriction of passive ROM more than 25 percent in two or more motions compared to the healthy side. 5. Voluntary agreement to participate with written informed consent.

Exclusion criteria

Exclusion criteria: 1. Rotator cuff tear. 2. Previous history of surgery or significant injury on shoulder. 3. Shoulder pain accompanied with stroke, spinal cord injury, or other surgeries. 4. Systemic pathology, including inflammatory joint disease or tumour. 5. Cervical spine or other upper limb joint disease which significantly affects the shoulder. 6. Intra-articular steroid injections within 3 months before participating in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Reduction in pain and increase in the shoulder joint mobility rangeTimepoint: 4 weeks

Secondary

MeasureTime frame
Reduction in inflammatory markers level such as ESR and CRPTimepoint: 4 weeks and 8 weeks

Countries

India

Contacts

Public ContactDrASHAMEEM FATHIMA

Government Siddha Medical College

drshameem31@gmail.com9840394568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026